Form CORRESP - Correspondence:
SEC Accession No. 0001144204-12-043637
Filing Date
2012-08-08
Accepted
2012-08-08 16:06:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 89584
2 GRAPHIC image_007.jpg GRAPHIC 3036
  Complete submission text file 0001144204-12-043637.txt   94904
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Morria Biopharmaceuticals PLC (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations